The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival among colorectal cancer patients with a history of previous cancer.
 
Sandi Pruitt
No Relationships to Disclose
 
David E. Gerber
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Samsung Bioepis
Research Funding - AstraZeneca (Inst); BerGenBio (Inst); Karyopharm Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending: “Prediction and Treatment of Immunotherapeutic Toxicity” (provisional, application number 62/461,455) (Inst); Royalties from Decision Support in Medicine from the Clinical Decision Support--Oncology on-line program.; Royalties from Oxford University Press from two books.
 
Hong Zhu
No Relationships to Disclose
 
Daniel Heitjan
Consulting or Advisory Role - Abbott; Braintree Laboratories; Creatics; Macrogenics
Expert Testimony - Noven; Women's Talc Project
 
Bhumika Maddineni
No Relationships to Disclose
 
Amit G Singal
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Exact Sciences; Exelixis; Genentech; Glycotest; Roche; Target Pharmasolutions; Wako Diagnostics
Research Funding - Abbvie (Inst); Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Eisai; Exelixis
 
Danyi Xiong
No Relationships to Disclose
 
Anna Tavakkoli
No Relationships to Disclose
 
Ethan Halm
No Relationships to Disclose
 
Caitlin C. Murphy
No Relationships to Disclose